Immunization of Patients with Metastatic Melanoma Using Both Class I- and Class II-Restricted Peptides from Melanoma-Associated Antigens-Reference-Cited by-同舟云学术

Immunization of Patients with Metastatic Melanoma Using Both Class I- and Class II-Restricted Peptides from Melanoma-Associated Antigens

Published:2003-07 Issue:4 Volume:26 Page:349-356
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:Journal of Immunotherapy

Author:

Phan Giao Q.,Touloukian Christopher E.,Yang James C.,Restifo Nicholas P.,Sherry Richard M.,Hwu Patrick,Topalian Suzanne L.,Schwartzentruber Douglas J.,Seipp Claudia A.,Freezer Linda J.,Morton Kathleen E.,Mavroukakis Sharon A.,White Donald E.,Rosenberg Steven A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference23 articles.

1. Durability of Complete Responses in Patients With Metastatic Cancer Treated With High-Dose Interleukin-2

2. High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

3. Factors Associated With Response to High-Dose Interleukin-2 in Patients With Metastatic Melanoma

4. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving potency of Nanoliposomal AE36 peptide vaccine by adding CD4+ T cell helper epitope and MPL in TUBO breast cancer mice model;Journal of Drug Delivery Science and Technology;2022-05

2. Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides;Cancer Immunology, Immunotherapy;2020-07-22

3. Identification and Characterization of an OSH1 Thiol Reductase from Populus trichocarpa;Cells;2019-12-27

4. Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators;Nature Nanotechnology;2019-08-05

5. Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform;International Journal of Pharmaceutics;2019-05